Reklama
WIG81 264,27-1,11%
WIG202 398,38-1,09%
EUR / PLN4,32+0,08%
USD / PLN3,98-0,09%
CHF / PLN4,50-0,19%
GBP / PLN5,05+0,22%
EUR / USD1,09+0,18%
DAX17 716,17-0,11%
FT-SE7 640,33-0,55%
CAC 407 956,41+0,28%
DJI38 999,79-0,22%
S&P 5005 137,66+0,01%
ROPA BRENT82,73-0,80%
ROPA WTI78,74-0,34%
ZŁOTO2 118,05+1,70%
SREBRO23,79+2,85%

Masz ciekawy temat? Napisz do nas

twitter
youtube
facebook
instagram
linkedin
Reklama
Reklama

SOPHARMA AD: Notification from Simeon Donev under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 4 December 2023. (2023-12-05 14:48)

ESPI | 15:48 05 grudzień 2023

freepik.com
Reklama
Aa
Udostępnij
facebook
twitter
linkedin
POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No209/2023
Date of issue:2023-12-05
Short name of the issuer
SOPHARMA AD
Subject
Notification from Simeon Donev under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 4 December 2023.
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Notification from Simeon Donev under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 4 December 2023.
Annexes
FileDescription
SDonev_SopharmaWarrants_Sell_EN_04122023.pdfNotification from Simeon Donev under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 4 December 2023.
SOPHARMA AD
(fullname of the issuer)
SOPHARMA ADFarmaceutyczny (far)
(short name of the issuer)(sector according to clasification
of the WSE in Warsow)
1220Sofia
(post code)(city)
IlienskoShosse16
(street)(number)
+359 2 813 42 00+359 2 936 02 86
(phone number)(fax)
(e-mail)(web site)
nd
(NIP)(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
DateNamePosition / FunctionSignature
2023-12-05Ognian DonevExecutive Director

Masz ciekawy temat? Napisz do nas

Chcesz, żebyśmy opisali Twoją historię albo zajęli się jakimś problemem?

Masz ciekawy temat? Napisz do nas

Napisz do redakcji

Reklama

Czytaj dalej